InvestorsHub Logo
Replies to #20214 on Biotech Values
icon url

DewDiligence

12/12/05 9:21 AM

#20215 RE: swampboots #20214

MYOG +50% in pre-market. Doesn’t seem justified given that this is only one of two pivotal trials in PAH and this is not even MYOG’s most important drug.